← All companies

VCNX

Vaccinex, Inc.

VCNX OTC Pharmaceutical Preparations EDGAR ↗

$1.15

-0.03 -2.54%

Key statistics

from XBRL data in SEC filings

Market cap

-$3.53M

Revenue (TTM)

$601K

Net income (TTM)

-$18.6M

EPS (TTM)

$-8.88

P/E ratio

—

Dividend yield

—

Free cash flow

-$16.2M

Cash

$1.11M

Total assets

$2.60M

Gross margin

—

52-week range

$0.31 – $1.50

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Director or officer change Mar 19, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Mar 7, 2025 8-K Delisting notice or listing-rule failure; Other events Dec 17, 2024 8-K Entered a material agreement; Unregistered sale of equity Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Delisting notice or listing-rule failure Oct 9, 2024 8-K Entered a material agreement; Unregistered sale of equity Sep 19, 2024 8-K Director or officer change Sep 13, 2024 8-K Other events Aug 20, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Regulation FD disclosure Aug 14, 2024 8-K Other events Jul 31, 2024 8-K Regulation FD disclosure Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Shareholder vote results May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 25, 2024 8-K Delisting notice or listing-rule failure Apr 12, 2024 10-K Fiscal year ended 2023-12-31 Apr 2, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws Apr 1, 2024 8-K Other events Mar 28, 2024 8-K Other events Mar 27, 2024 8-K Director or officer change Mar 4, 2024 8-K Other events Feb 21, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 15, 2024 8-K Shareholder vote results Feb 13, 2024 8-K/A Feb 8, 2024 8-K Entered a material agreement; Unregistered sale of equity Feb 7, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Regulation FD disclosure Oct 26, 2023 8-K Delisting notice or listing-rule failure; Other events Oct 13, 2023 8-K Entered a material agreement Oct 4, 2023 8-K Regulation FD disclosure Sep 27, 2023 8-K Regulation FD disclosure Sep 26, 2023 8-K Modified rights of security holders; Amended charter or bylaws; Other events Sep 22, 2023 8-K Entered a material agreement; Unregistered sale of equity Sep 22, 2023 8-K Shareholder vote results Sep 13, 2023 8-K Entered a material agreement; Unregistered sale of equity Aug 22, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Delisting notice or listing-rule failure May 30, 2023